Arcellx Future Growth
Future criteria checks 2/6
Arcellx is forecast to grow earnings and revenue by 53.4% and 48.2% per annum respectively. EPS is expected to grow by 51.3% per annum. Return on equity is forecast to be -7.4% in 3 years.
Key information
53.4%
Earnings growth rate
51.32%
EPS growth rate
| Biotechs earnings growth | 25.4% |
| Revenue growth rate | 48.2% |
| Future return on equity | -7.43% |
| Analyst coverage | Good |
| Last updated | 16 Oct 2025 |
Recent future growth updates
Recent updates
Analysts Have Lowered Expectations For Arcellx, Inc. (NASDAQ:ACLX) After Its Latest Results
Aug 10
Arcellx: Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market
Jul 15We're Not Very Worried About Arcellx's (NASDAQ:ACLX) Cash Burn Rate
Jul 11We Think Arcellx (NASDAQ:ACLX) Can Easily Afford To Drive Business Growth
Apr 09Arcellx Impressive Safety Data Leaves Doubts
Mar 17Need To Know: Analysts Just Made A Substantial Cut To Their Arcellx, Inc. (NASDAQ:ACLX) Estimates
Mar 05Arcellx, Inc.: Trying To Build A Better Myeloma Cell Therapy
Jan 16Risks To Shareholder Returns Are Elevated At These Prices For Arcellx, Inc. (NASDAQ:ACLX)
Dec 20A Look At The Fair Value Of Arcellx, Inc. (NASDAQ:ACLX)
Oct 28Arcellx's Anito-Cel: Compelling Opportunity As Potential Best-In-Class CAR-T Therapy For Multiple Myeloma
Sep 10Arcellx: Navigating The CAR T-Cell Revolution
Jan 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 252 | -122 | -40 | 12 | 13 |
| 12/31/2026 | 130 | -197 | -117 | -119 | 16 |
| 12/31/2025 | 56 | -224 | -169 | -165 | 17 |
| 6/30/2025 | 57 | -188 | -123 | -118 | N/A |
| 3/31/2025 | 77 | -162 | -122 | -115 | N/A |
| 12/31/2024 | 108 | -107 | -97 | -83 | N/A |
| 9/30/2024 | 156 | -40 | 4 | 21 | N/A |
| 6/30/2024 | 145 | -54 | -43 | -20 | N/A |
| 3/31/2024 | 132 | -51 | -33 | -6 | N/A |
| 12/31/2023 | 110 | -71 | 186 | 208 | N/A |
| 9/30/2023 | 47 | -130 | 104 | 122 | N/A |
| 6/30/2023 | 32 | -183 | 105 | 115 | N/A |
| 3/31/2023 | 18 | -190 | 113 | 115 | N/A |
| 12/31/2022 | N/A | -189 | -102 | -99 | N/A |
| 9/30/2022 | N/A | -170 | -99 | -93 | N/A |
| 6/30/2022 | N/A | -95 | -94 | -89 | N/A |
| 3/31/2022 | N/A | -80 | -83 | -77 | N/A |
| 12/31/2021 | N/A | -65 | -60 | -54 | N/A |
| 9/30/2021 | N/A | -53 | -42 | -40 | N/A |
| 12/31/2020 | N/A | -32 | -30 | -29 | N/A |
| 12/31/2019 | N/A | -18 | -23 | -19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACLX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ACLX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ACLX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ACLX's revenue (48.2% per year) is forecast to grow faster than the US market (10% per year).
High Growth Revenue: ACLX's revenue (48.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ACLX is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/16 18:04 |
| End of Day Share Price | 2025/10/16 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arcellx, Inc. is covered by 26 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jack Allen | Baird |
| Carter Gould | Barclays |
| Peter Lawson | Barclays |